Microbiología y parasitología

2015

1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

   Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9

2. Análisis de la efectividad del plan de atención al paciente pluripatológico en el servicio de Medicina Interna del Hospital Universitario Basurto

   Gaceta Medica de Bilbao, Vol. 112, Núm. 4, pp. 151-156

3. Biofilm formation and quorum-sensing-molecule production by clinical isolates of Serratia liquefaciens

   Applied and Environmental Microbiology, Vol. 81, Núm. 10, pp. 3306-3315

4. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

   Journal of Infection, Vol. 71, Núm. 3, pp. 385-394

5. Contrast-associated acute kidney injury (CA-AKI) according to the type and dose of contrast in contrast-enhanced radiographic examinations. Preliminay results of the nefrocon study

   Intensive Care Medicine Experimental

6. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

   Medicine (United States), Vol. 94, Núm. 43

7. Dermatitis by Dermatophilus congolensis

   Clinical Microbiology and Infection

8. Detection of bacteria and viruses in the pleural effusion of children and adults with community-acquired pneumonia

   Future Microbiology, Vol. 10, Núm. 6, pp. 909-915

9. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases

   Revista Iberoamericana de Micologia, Vol. 32, Núm. 3, pp. 190-196

10. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

11. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

12. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10

13. Espondilodiscitis cervical por Streptococcus agalactiae y síndrome de Parsonage-Turner secundario

    Revista CES Medicina, Vol. 29, Núm. 1, pp. 101-108

14. Human papillomavirus 16 variants may be identified by E6 gene analysis

    Intervirology, Vol. 58, Núm. 3, pp. 143-148

15. Is contrast-associated acute kidney injury (CA-AKI) associated to the type of hospital and ICU? preliminay results of the nefrocon study

    Intensive Care Medicine Experimental , Vol. 3

16. Left-sided infective endocarditis in patients with liver cirrhosis

    Journal of Infection, Vol. 71, Núm. 6, pp. 627-641

17. Mortalidad en las primeras 48 horas del ingreso en un servicio de cirugía general y digestiva

    Revista española de investigaciones quirúrgicas, Vol. 18, Núm. 1, pp. 3-6

18. Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and Monte Carlo simulation

    Intensive Care Medicine Experimental

19. Outbreak of acute gastroenteritis caused by contamination of drinking water in a factory, the Basque Country

    Journal of Water and Health, Vol. 13, Núm. 1, pp. 168-173

20. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function

    International Journal of Antimicrobial Agents, Vol. 45, Núm. 4, pp. 399-405